Brad Gill
About Brad Gill
Brad Gill serves as the Executive Cell Therapy Account Specialist at Kite Pharma, a position he has held since 2020. He has extensive experience in the pharmaceutical industry, having worked in various therapeutic roles at Gilead Sciences prior to his current role.
Work at Kite Pharma
Brad Gill has served as an Executive Cell Therapy Account Specialist at Kite Pharma since 2020. In this role, he focuses on promoting and supporting cell therapy solutions across various regions, including Columbus, Cleveland, Akron, Canton, and Youngstown, Ohio. His responsibilities involve engaging with healthcare professionals and stakeholders to enhance the understanding and adoption of Kite Pharma's innovative therapies.
Previous Experience at Gilead Sciences
Before joining Kite Pharma, Brad Gill worked at Gilead Sciences for a total of 15 years. He held the position of Executive Therapeutic Specialist in Oncology from 2014 to 2020, where he was responsible for driving oncology product initiatives in the Columbus area. Prior to that, he served as an Executive Therapeutic Specialist in Cardiology from 2005 to 2014, focusing on cardiology products in the Columbus, Ohio area.
Education and Expertise
Brad Gill earned a Bachelor of Science (B.S.) degree in Finance from The Ohio State University, where he studied from 1990 to 1995. His educational background in finance complements his extensive experience in the pharmaceutical industry, particularly in therapeutic specialties, enabling him to navigate complex market dynamics effectively.
Career Timeline
Brad Gill's career spans over two decades in the pharmaceutical sector. He began his tenure at Gilead Sciences in 2005, where he spent nine years in cardiology before transitioning to oncology for six years. In 2020, he joined Kite Pharma, marking a new phase in his professional journey focused on cell therapy.